2020-2027 Analysis and Review Dried Aluminium Hydroxide Gels Market

Dried Aluminium Hydroxide Gels Market

Dried Aluminium Hydroxide Gels Market By Clinical Application (Antacid, Hyperphosphatemia and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

08-06-2020 REP-HC-5110 40 Tables 110 pages Format

The dried aluminium hydroxide gels market was valued at USD 577.5 Mn by 2019. Rising prevalence of gastric acidity and indigestion worldwide primarily drives the dried aluminium hydroxide gels market growth. Furthermore, the growing incidence of hyperphosphatemia in patients suffering from renal disease will further accentuate the dried aluminium hydroxide gels market growth.

Dried Aluminium Hydroxide Gels Market

Dried aluminium hydroxide gels are also popularly known as aluminium hydroxide gels, it is either used alone or in combination with magnesium hydroxide and simethicone for the treatment of acidity. It needs to be taken judiciously in order to prevent the occurrence of side effects such as constipation, rash itching etc. It is important to understand that while taking aluminium hydroxide enriched drug molecule the consumer should avoid intake of food rich in citrate as it may increase the absorption of aluminium and cause severe toxicity.

The major segments related to the dried aluminium hydroxide gels market are: 

By Clinical Application (2017–2027; US$ Mn)

Antacid

Hyperphosphatemia

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global dried aluminium hydroxide gels market
  • The overall segmentation of the dried aluminium hydroxide gels market, by clinical application, distribution channel and geography is minutely studied. Antacid and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of gastric disorders worldwide
  • Significant increase in the number of patients suffering from hyperphosphatemia with chronic kidney disease

Report gist?

  • The study of the global dried aluminium hydroxide gels market includes qualitative analysis of factors such as drivers, restraints and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of dried aluminium hydroxide gels due to the rising prevalence of heartburns and acidity worldwide
  • The report will benefit formulation scientist engaged in the development of dried aluminium hydroxide gels drug formulation for the treatment of hyperphosphatemia in patients suffering from chronic kidney disease
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to dried aluminium hydroxide gels market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

An antacid is representing the largest market share in the clinical application segment for dried aluminium hydroxide gels market. It is a very popular inorganic salt which is prescribed as an antacid by physicians worldwide. It is basic in nature and is beneficial in neutralizing the hydrochloric acid produced in gastric secretions, hence the subsequent increase in the pH inhibits the action of pepsin and a simultaneous increase in the levels of bicarbonate ions and prostaglandins ensure cytoprotective effects. Hyperphosphatemia is keen to register impressive market growth on account of the increasing formulation and development activities conducted in pharmaceutical industries in adjusting the dose of dried aluminium hydroxide gels for the treatment of hyperphosphatemia in patients suffering from chronic kidney disease.

Hospital pharmacy is presently reigning the distribution channel segment for dried aluminium hydroxide gels market. Precise compounding by hospital pharmacist is mandatory while dispensing medicines for patients suffering from hyperphosphatemia due to chronic kidney disease. Retail pharmacy is expected to register comfortable market growth owing to the constant surge observed in the over the counter (OTC) products and generic drugs market in the developing regions.

North America is currently leading the geography segment for dried aluminium hydroxide gels market. Rising prevalence of gastric acidity primarily drives the market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 30% of the United States population is suffering from gastric acidity. Increasing consumption of alcohol, craving for fast food, obesity is the major causative factors responsible for the occurrence of gastric acidity in the region. Affordable reimbursement scenario for the dried aluminium hydroxide gels drugs formulation further accelerates the market growth in the region. Europe is placed 2nd in the regional segment on account of the strategic partnership between research academia and pharmaceutical companies to determine the dosage regimen of dried aluminium hydroxide gels in the treatment of hyperphosphatemia in patients suffering from chronic kidney disease. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of flourishing over the counter (OTC) products market and the emergence of local players.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.